Belgium· BE-AMP-SAM666123-00
Joenja 70 mg
A leniolisib product containing leniolisib phosphate, registered in Belgium by Pharming Technologies. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Leniolisib is registered in 11 of 19 countries.
Countries holding a registration under ATC L03AX22 (leniolisib), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Leniolisib · ATC L03AX22
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Leniolisib Phosphate
- Manufacturer
- Pharming Technologies
- Country
- Belgium (BE)
- ATC code
- L03AX22
- ATC class
- Leniolisib
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Leniolisib in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJOENJAPharming Technologies B.V., Leiden
- United StatesJoenjaPharming Healthcare Inc.
- IrelandJoenja 70 mg film-coated tabletsPharming Technologies B.V.
- IcelandJoenjaPharming Technologies B.V.
- NetherlandsJoenja 70 mg, filmomhulde tablettenPharming Technologies B.V.
- PolandJoenjaPharming Technologies B.V.
- SwedenJoenja 70 mg Filmdragerad tablettPharming Technologies B.V.
- FinlandJoenjaPharming Technologies B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Joenja
- Liechtenstein · Joenja
- Norway · Joenja
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/72da82bb-0d7f-4832-91b8-c0724648ee62 GET /v1/drugs/72da82bb-0d7f-4832-91b8-c0724648ee62?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Joenja 70 mg",
"name_fr": "Joenja 70 mg",
"name_nl": "Joenja 70 mg",
"amp_code": "SAM666123-00",
"strengths": [
"70.0000",
"70.0000",
"241.1600"
],
"pack_count": 1,
"substances": [
"Leniolisib Phosphate",
"Leniolisib",
"Lactose Monohydrate",
"Sodium Starch Glycolate (Type A)"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Leniolisib",
"authorisation_numbers": [
"EU/1/26/2034/001"
]
}See everything about leniolisib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.